Cargando…

IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety

OBJECTIVES: Small-fiber polyneuropathy (SFPN) has various underlying causes, including associations with systemic autoimmune conditions. We have proposed a new cause; small-fiber-targeting autoimmune diseases akin to Guillain-Barré and chronic inflammatory demyelinating polyneuropathy (CIDP). There...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaolei, Treister, Roi, Lang, Magdalena, Oaklander, Anne Louise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791555/ https://www.ncbi.nlm.nih.gov/pubmed/29403541 http://dx.doi.org/10.1177/1756285617744484

Ejemplares similares

Specific symptoms may discriminate between fibromyalgia patients with vs without objective test evidence of small-fiber polyneuropathy
por: Lodahl, Mette, et al.
Publicado: (2017)

Repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex for treating facial neuropathic pain – preliminary results of a randomized, sham-controlled, cross-over study
por: Lang, Magdalena, et al.
Publicado: (2014)

Non-invasive Transcranial Magnetic Stimulation (TMS) of the Motor Cortex for Neuropathic Pain—At the Tipping Point?
por: Treister, Roi, et al.
Publicado: (2013)

Association of small-fiber polyneuropathy with three previously unassociated rare missense SCN9A variants
por: Kelley, Mary A., et al.
Publicado: (2020)

Small-fiber polyneuropathy (SFPN), a common underlying diagnosis in syndromes involving unexplained chronic pain and multi-system symptoms
por: Oaklander, Anne Louise, et al.
Publicado: (2014)

Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes
por: Breiner, Ari, et al.
Publicado: (2019)

Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy
por: Cornblath, David R, et al.
Publicado: (2022)

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
por: Merkies, Ingemar S.J., et al.
Publicado: (2019)

Langerhans cell activation in diabetic small fiber polyneuropathy
por: Piccione, Ezequiel Agustin, et al.
Publicado: (2014)

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
por: Blackhouse, Gord, et al.
Publicado: (2010)

Quality of life in polyneuropathy: association with biomarkers of small fiber impairment
por: Lin, Meng-Ting, et al.
Publicado: (2015)

Fibromyalgia syndrome and small fiber, early or mild sensory polyneuropathy
por: Lawson, Victoria H., et al.
Publicado: (2018)

Overnight loss of pigmented hair in autoimmune autonomic neuropathy treated with IVIg
por: Turner, Lindsey E., et al.
Publicado: (2019)

Treatment of scleromyxedema with IVIg
por: Moser, David W, et al.
Publicado: (2012)

Subacute Sensorimotor Polyneuropathy Associated with Autoimmune Hepatitis
por: Park, Kee Hong, et al.
Publicado: (2016)

Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
por: Wang, Zhouping, et al.
Publicado: (2020)

Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
por: Belmokhtar, Chafké, et al.
Publicado: (2019)

Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions
por: Klemencic Kozul, Tara, et al.
Publicado: (2022)

Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
por: Wasserman, Richard L., et al.
Publicado: (2012)

Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
por: Dalakas, Marinos C.
Publicado: (2021)

A Comparative Study of IVIG versus IVIG with IV Methylprednisolone in Guillain–Barre Syndrome
por: Bhattiprolu, Rahi Kiran, et al.
Publicado: (2020)

Transcranial magnetic stimulation of the brain: guidelines for pain treatment research
por: Klein, Max M., et al.
Publicado: (2015)

Successful Treatment of Autoimmune Hemolytic Anemia with Steroid, IVIg, and Plasmapheresis in a Haploidentical Transplant Recipient
por: Uz, Burak, et al.
Publicado: (2012)

Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)
por: Straubel, Diana, et al.
Publicado: (2018)

Cooling down VITT with IVIG
por: Lentz, Steven R.
Publicado: (2021)

Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease
por: Han, Chun-Ling, et al.
Publicado: (2018)

Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
por: Pourahmad, Ramtin, et al.
Publicado: (2020)

Study on the Treatment of ITP Mice with IVIG Sourced from Distinct Sex-Special Plasma (DSP-IVIG)
por: Zhang, Wei, et al.
Publicado: (2023)

The unhappy postdoc: a survey based study
por: Grinstein, Amir, et al.
Publicado: (2018)

Acute Inflammatory Demyelinating Polyneuropathy (AIDP) Masked by Autoimmune Thyroiditis
por: Wirtshafter, Stephanie, et al.
Publicado: (2021)

Efficacy of IVIG therapy for patients with sepsis: a systematic review and meta-analysis
por: Pan, Bo, et al.
Publicado: (2023)

Eczematous reaction to IVIG for the treatment of dermatomyositis()()
por: Berk-Krauss, J., et al.
Publicado: (2018)

Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study
por: Zhu, Xiao-Lu, et al.
Publicado: (2022)

Therapeutic Window of Intravenous Immunoglobulin (IVIG) and its correlation with IVIG-resistant in Kawasaki Disease: a retrospective study
por: Cai, Jiang Hui, et al.
Publicado: (2022)

Stiff-Leg Syndrome Associated with Autoimmune Retinopathy and Its Treatment with IVIg—A Case Report and Review of the Literature
por: Papadopoulos, Vassilis E., et al.
Publicado: (2023)

Updated Evaluation of the Safety, Efficacy and Tolerability of Tafamidis in the Treatment of Hereditary Transthyretin Amyloid Polyneuropathy
por: Falcão de Campos, Catarina, et al.
Publicado: (2023)

Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease
por: Zhang, Hao, et al.
Publicado: (2022)

A Rare Case of Autoimmune Demyelinating Polyneuropathy and Hydrocephalus Secondary to Pembrolizumab
por: Arora, Aakriti, et al.
Publicado: (2020)

Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review
por: Pinto, Ashwin A., et al.
Publicado: (2023)

IVIG Treatment and Prognosis in Guillain–Barré Syndrome
por: van Doorn, Pieter A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_e2pd9lha3ooo055100og1og22l